CMS Launches Office of Health Technology Products to Steer AI and Interoperability Policy
The Centers for Medicare & Medicaid Services has established a new Office of Health Technology Products, giving the agency a dedicated home for artificial intelligence, interoperability, and digital health policy across the Medicare and Medicaid programs.
The move is one of the clearest signals yet that health technology has graduated from a niche concern to a central pillar of federal healthcare strategy. With telehealth now accounting for more than 30% of outpatient visits and the CPT 2026 code set formally recognizing remote monitoring and AI diagnostic services, the machinery of American healthcare reimbursement is being rebuilt around digital care.
Why it matters
Until now, digital health policy at CMS has been scattered across program offices, leaving vendors and health systems to navigate inconsistent guidance on AI tools, data exchange requirements, and virtual care billing. A single accountable office creates a front door — and, industry observers hope, a faster and more predictable path from innovation to coverage.
The office will oversee AI, interoperability, and digital health product policy across Medicare and Medicaid — a consolidation the industry has requested for years.
The wider policy picture
The launch lands amid a flurry of related activity. On Capitol Hill, Rep. Jahana Hayes introduced H.R. 9431, the Fair Telehealth Billing Act of 2026, which would prohibit separate facility fees when professional fees are already billed for a telehealth visit. The American Telemedicine Association, meanwhile, is pressing for permanent Medicare telehealth flexibilities, cross-state licensure pathways, and reimbursement for prescription digital therapeutics.
Globally, the WHO has issued guidance drawing a sharp distinction between AI used as an analytical support tool and AI acting as an autonomous decision-maker — flagging bias and over-optimization as core risks regulators must manage.
What to watch
Early tests for the new office will include how it handles coverage determinations for AI-enabled diagnostics, whether it accelerates TEFCA-aligned interoperability enforcement, and how quickly it can publish guidance vendors can actually build against. For a sector that raised $7.4 billion in the first half of 2026 alone, the stakes are not small.